Study Phase 3

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17deacetyl-norgestimate and Ethinyl Estradiol

Trial Information

Generic NameNorelgestrominProduct NameMONONESSA ® ORTHO-CYCLEN ® ORTHO TRI-CYCLEN ® TRINESSA ®Therapeutic AreaUrinary Tract, Sexual Organs, and Pregnancy ConditionsEnrollment1751% Female100%% White91%
Product ClassOB/GYNSponsor Protocol NumberNRGEEP-CONT-002Data PartnerJohnson & JohnsonCondition StudiedContraceptionMean/Median Age (Years)28.7

Supporting Documentation

  • Collected Datasets Available
  • Protocol with Amendments Available
  • Statistical Analysis Plan Available

Approved Data Requests Associated with this Trial


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.